MANUEL EDUARDO
MUÑOZ TORRES
CATEDRÁTICO DE UNIVERSIDAD
Hospital General de Ciudad Real
Ciudad Real, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Ciudad Real (24)
2022
-
Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539
2020
-
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215
2018
-
Circulating levels of sclerostin are associated with cardiovascular mortality
PLoS ONE, Vol. 13, Núm. 6
2017
-
Recommendations on the effect of antidiabetic drugs in bone
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 1-6
-
Recommended vitamin D levels in the general population
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 7-14
2016
-
Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study
Talanta, Vol. 148, pp. 135-143
-
Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
Endocrine, Vol. 52, Núm. 1, pp. 54-62
-
Serum dickkopf1 (DKK1), bone metabolism and atherosclerotic disease in patients with type 2 diabetes
Revista de Osteoporosis y Metabolismo Mineral, Vol. 8, Núm. 1, pp. 24-29
2015
-
Relationship between proinflammatory and antioxidant proteins with the severity of cardiovascular disease in type 2 diabetes mellitus
International Journal of Molecular Sciences, Vol. 16, Núm. 5, pp. 9469-9483
2014
-
Bone turnover markers in patients with prostate carcinoma: Influence of sex steroids levels
Journal of Bone and Mineral Metabolism, Vol. 32, Núm. 1, pp. 65-70
-
Erratum to Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels [J Bone Miner Metab, DOI 10.1007/s00774-013-0466-5]
Journal of Bone and Mineral Metabolism
-
FGF23 in type 2 diabetic patients: Relationship with bone metabolism and vascular disease
Diabetes Care
-
Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
PLoS ONE, Vol. 9, Núm. 11
2013
-
Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels
Diabetes Care, Vol. 36, Núm. 6, pp. 1667-1674
-
Ischemic heart disease is associated with vertebral fractures in patients with type 2 diabetes mellitus
Journal of Diabetes Investigation, Vol. 4, Núm. 3, pp. 310-315
-
Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
Acta Diabetologica, Vol. 50, Núm. 1, pp. 47-52
-
Serum osteoprotegerin: Bone or cardiovascular marker in Type 2 diabetes males?
Journal of Endocrinological Investigation, Vol. 36, Núm. 1, pp. 16-20
2012
-
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus
Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1, pp. 234-241
-
Enfermedad cardiovascular, osteoporosis y riesgo de fractura
Revista Clinica Espanola, Vol. 212, Núm. 4, pp. 188-192
-
Fe de errores de "Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales"
Endocrinologia y Nutricion